Boehringer Ingelheim applies for clearance to acquire Merial from Sanofi
The Commerce Commission has received an application from Boehringer Ingelheim International GmbH seeking clearance to
acquire 100% of the shares and assets in Merial, the animal health business of Sanofi SA.
Boehringer Ingelheim and Sanofi are global manufacturers of pharmaceutical and vitamin products for humans and for
animals, which they each distribute in New Zealand.
While Boehringer Ingelheim’s clearance application relates only to animal health products, the Commission will also
consider whether the proposed global transaction might impact on competition in any other markets in New Zealand.
A public version of the clearance application is available on the Commission’sClearances Register.
ends